Application 077075

Type
ANDA
Sponsor
VINTAGE PHARMS LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001GILDESS FE 1.5/30ETHINYL ESTRADIOL; NORETHINDRONE ACETATETABLET;ORAL-280.03MG;1.5MGNoNo
002GILDESS 1.5/30ETHINYL ESTRADIOL; NORETHINDRONE ACETATETABLET;ORAL-210.03MG;1.5MGNoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A077075-001GILDESS FE 1.5/30ETHINYL ESTRADIOL; NORETHINDRONE ACETATE0.03MG;1.5MGTABLET / ORAL-282005-04-28
A077075-002GILDESS 1.5/30ETHINYL ESTRADIOL; NORETHINDRONE ACETATE0.03MG;1.5MGTABLET / ORAL-212012-07-24

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 3 · 90 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A077075-001GILDESS FE 1.5/300.03MG;1.5MGTABLET / ORAL-282005-04-283a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A077075-002GILDESS 1.5/300.03MG;1.5MGTABLET / ORAL-212012-07-243a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A077075-001GILDESS FE 1.5/300.03MG;1.5MGTABLET / ORAL-282005-04-28f41ea6bd6efb…
2022-10-28 04:53 UTC2022-10A077075-002GILDESS 1.5/300.03MG;1.5MGTABLET / ORAL-212012-07-24f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09A077075-001GILDESS FE 1.5/300.03MG;1.5MGTABLET / ORAL-282005-04-28e64feba35796…
2022-09-29 23:25 UTC2022-09A077075-002GILDESS 1.5/300.03MG;1.5MGTABLET / ORAL-212012-07-24e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A077075-001GILDESS FE 1.5/300.03MG;1.5MGTABLET / ORAL-282005-04-28cb3db0bc1861…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07A077075-002GILDESS 1.5/300.03MG;1.5MGTABLET / ORAL-212012-07-24cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A077075-001GILDESS FE 1.5/300.03MG;1.5MGTABLET / ORAL-282005-04-28a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A077075-002GILDESS 1.5/300.03MG;1.5MGTABLET / ORAL-212012-07-24a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2019-12-13 00:20 UTC2019-12A077075-001AB174a2ff9319b5…
2019-12-13 00:20 UTC2019-12A077075-002AB174a2ff9319b5…
2019-12-14 00:12 UTC2019-12A077075-001AB13f01610625f2…
2019-12-14 00:12 UTC2019-12A077075-002AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A077075-001AB1b00525d2431f…
2019-09-15 20:21 UTC2019-09A077075-002AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A077075-001AB1ea99ee380514…
2019-07-19 19:46 UTC2019-07A077075-002AB1ea99ee380514…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.